2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on Solid H&N Tumors With HRAS Mutations: Is Tipifarnib a Good Option for Post-Chemo Patients With SCCHN? Does Axitinib Improve Overall Outcomes?

20 views
September 29, 2020
Comments 0
Login to view comments. Click here to Login